Timo Strid
For healthcare professionals and clinicians requiring rapid, standardized risk assessment and neurological evaluation tools.
Snapshot
Who is Timo Strid?
Providing clinical utility tools for healthcare professionals to assist in neurological assessment and risk stratification.
Target audience
Portfolio
Free 1Last updated
Glasgow Coma Scale - SOG
v4.0
2.2y ago
Publisher DNA
What defines Timo Strid?
Publisher DNA
Primary focus
Medical utility and clinical calculation tools
Scale
indie
Target audience
Healthcare professionals and clinicians requiring rapid, standardized risk assessment and neurological evaluation tools.
Signature Patterns
- •Focus on medical calculators based on standardized clinical research
- •Minimalist, single-page interface design
- •Utility-first approach with no social or engagement features
- •Mixed monetization model including free and paid clinical tools
Portfolio momentum
The portfolio shows limited activity with only 1 release in the last 6 months and a mix of active and abandoned titles.
Portfolio
What does Timo Strid ship?
Apps
2 apps analysed
Rivals
Who does Timo Strid compete with?
The rivals identified
Nemeses(1)
Both applications target healthcare professionals managing anticoagulation therapy for patients with atrial fibrillation. They compete directly for the same clinical workflow utility.
Contenders(4)
Both apps target healthcare professionals managing atrial fibrillation patients, creating a shared clinical workflow where clinicians require both bleeding and thromboembolic risk scores during patient encounters.
Both apps target healthcare professionals managing atrial fibrillation patients, with AntiCoagAF providing broader anticoagulant selection guidance while HAS-BLED focuses specifically on bleeding risk stratification.
Both apps provide clinical risk stratification tools for cardiovascular patients, though they target distinct patient populations and medical conditions.
CCPN SPAF Tool competes by bundling HAS-BLED calculations with broader stroke prevention criteria and drug management tools, targeting the same healthcare professional audience.
Same space(11)
AnticoagEvaluator provides therapy guidance for atrial fibrillation, serving as an adjacent tool for clinicians managing antithrombotic therapy.
Cardio Tools aggregates multiple cardiology scales, providing a broader utility for clinicians than the single-purpose HAS-BLED app.
Anticoagulation Manager focuses on dosage and laboratory testing, providing clinical support for the same patient population as HAS-BLED.
RapidASCVD provides cardiovascular risk assessment, offering a high-speed alternative for clinicians requiring quick calculations.
Atrial Fibrillation provides educational simulations, serving as a training resource for the same clinical audience as HAS-BLED.
CliniCalc provides a broad library of clinical formulas, whereas HAS-BLED focuses on a single bleeding risk score.
Warfarin Wise is a patient-facing tool for therapy management, contrasting with the clinician-focused utility of HAS-BLED.
AF Stroke Risk provides stroke risk assessment, acting as a companion tool to the bleeding risk assessment in HAS-BLED.
ASCVD Risk provides cardiovascular assessment within a larger system, offering more functionality than the standalone HAS-BLED app.
Framingham Cardiovascular Risk estimates long-term event probability, providing a different clinical metric than the HAS-BLED bleeding score.
MAQI2 offers a specialized anticoagulation management resource, complementing the risk stratification provided by HAS-BLED.
The Analyst's Read
The bottom line on Timo Strid
Bottom line
The publisher maintains a narrow, functional niche in the medical utility space. Their value proposition relies entirely on the accuracy and speed of their clinical calculators for professional use.
Frequently asked questions
How many apps does Timo Strid publish?
What kind of apps does Timo Strid make?
What is Timo Strid's top app?
What fed this analysis
- Apps analyzed:
- 2
- With full intel:
- 0
- With overview:
- 2
- Website scraped:
- yes
- Social presence:
- yes